Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.
Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.
Henry Schein (Nasdaq: HSIC) has partnered with the American Association of Dental Office Management (AADOM) to present the Green Leader Award to Jennifer Z. Vickery, VP of Operations at Ocean Dental, recognizing her efforts in promoting sustainability across 15 clinics. Presented at the AADOM Conference in Scottsdale, Arizona, the award highlights her initiatives, including transitioning to paperless practices and implementing eco-friendly policies. AADOM aims to empower dental practices to reduce their environmental impact, a mission supported by Henry Schein.
Henry Schein, listed on Nasdaq as HSIC, announced its participation in three upcoming investor conferences. These include the Piper Sandler’s 34th Annual Healthcare Conference on November 30, 2022, at 9:00 a.m. ET, the Evercore ISI HealthCONx Virtual Conference on December 1, 2022, at 11:20 a.m. ET, and the Nasdaq 47th Investor Conference in London on December 6, 2022, at 10:30 a.m. GMT / 5:30 a.m. ET. Presentations will be available via live webcast and replays on the company’s website.
Henry Schein reported third-quarter 2022 net sales of $3.1 billion, a 3.5% decline from Q3 2021. Internal sales growth, excluding PPE and COVID-19 products, rose 6.8% in local currencies. GAAP diluted EPS for the quarter was $1.09, down from $1.15 year-over-year, while non-GAAP diluted EPS increased to $1.15 from $1.10. The full-year 2022 non-GAAP diluted EPS guidance is narrowed to $4.79 to $4.87, reflecting a potential growth of 6% to 8% compared to 2021. The company expects full-year sales growth of 1.5% to 2.5%.
Henry Schein, trading under NASDAQ: HSIC, announces its participation in two investor conferences in November 2022. The first is Credit Suisse's 31st Annual Healthcare Conference on November 9 at the Terranea Resort, California, followed by Stifel's 2022 Healthcare Conference on November 15 at the Lotte New York Palace, New York City. Both presentations will be available via live webcast on the company's website and replays will be accessible afterward. Henry Schein is a leader in healthcare solutions, serving over 1 million customers globally.
Henry Schein (NASDAQ: HSIC) announced that Steven W. Kess, Vice President of Global Professional Relations, received a Presidential Citation from the American Dental Association (ADA) during SmileCon 2022 in Houston, Texas, on October 13. This recognition honors significant contributions to public oral health, particularly through the Give Kids A Smile program, which has served over seven million children since 2003. Kess emphasized ongoing efforts to enhance access to oral care for underserved communities.
Smile Brands has selected Dentrix Ascend as its exclusive cloud-based practice management system for its 700 dental locations. The decision followed a year-long market analysis and pilot program, confirming Dentrix Ascend's superior clinical features and integration capabilities. This software will enhance operational efficiency by allowing remote access to data and reducing management burdens. CEO Steve Bilt emphasized that this partnership aligns with their vision of improving patient experiences. Henry Schein One, the software provider, supports this initiative aiming for enhanced quality of care.
Henry Schein, Inc. announces a donation of up to $500,000 for Hurricane relief efforts, including cash and healthcare products. The Henry Schein Cares Foundation is establishing a Disaster Relief Fund with $50,000, matching employee contributions up to $50,000. The company will donate $350,000 worth of health care supplies to affected areas in Florida, Puerto Rico, and Eastern Canada. Customer assistance is available via a 24/7 hotline for operational issues caused by the hurricanes.
Henry Schein (Nasdaq: HSIC) has been recognized in FORTUNE® magazine's "Change the World" list for its initiatives to advance health equity for individuals with disabilities. This marks the third acknowledgment for the company, highlighting its commitment to addressing care gaps for 61 million people in the U.S. living with disabilities. Key efforts include public-private partnerships, educating healthcare professionals, and designing accessible dental products. The company emphasizes that strong financial performance aligns with its mission for societal impact.
Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of health care solutions for dental and medical practitioners, will release its Q3 2022 financial results on November 1, 2022. The earnings conference call starts at 10:00 a.m. Eastern time on the same day, featuring CEO Stanley M. Bergman and CFO Ronald N. South. Investors can access the live webcast on the company’s website. Henry Schein reported $12.4 billion in sales for 2021 and operates in 32 countries with a strong distribution network.
Henry Schein (Nasdaq: HSIC) has launched its 16th annual Practice Pink program, raising over $1.8 million for cancer-related nonprofit organizations. This global initiative aims to promote awareness and support for cancer research and prevention through the sale of pink-themed products. The program collaborates with various organizations, including the American Cancer Society and others in the U.S. and Europe, to aid in breast cancer awareness and research efforts.